CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Mizuho Raises Price Target on Spyre Therapeutics to $120 From $84, Keeps Outperform Rating

Positive
AI Analysis

Summary

Mizuho raised its price target on Spyre Therapeutics from $84 to $120 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.60
price_target_raiseanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 10:58 AM

Read Original